Ticker Report Assenagon Asset Management S.A. raised its holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) by 267.2% during the 2nd quarter, according to its most recent disclosure with the...\n more…
Ticker Report PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) - Research analysts at HC Wainwright cut their Q3 2024 earnings per share (EPS) estimates for PMV Pharmaceuticals in a research note issued on...\n more…
Ticker Report HC Wainwright restated their buy rating on shares of PMV Pharmaceuticals (NASDAQ:PMVP - Free Report) in a report published on Tuesday, Benzinga reports. The brokerage currently has a $5.00 price...\n more…
Globe Newswire Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 60% of sites...\n more…
Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...\n more…
Zolmax Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP - Free Report) in the first quarter, according to its most recent filing with the...\n more…